01841nam 2200373Ia 450 991069890110332120090430151133.0(CKB)5470000002396850(OCoLC)319711616(EXLCZ)99547000000239685020090430d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierQ4B, annex 3, evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on test for particulate contamination, sub-visible particles[electronic resource] /International Conference on Harrmonisation of Technical Requrements for Registration of Pharmaceuticals for Human Use[Rockville, MD] :[U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research],[2007]7 unnumbered pages digital, PDF fileTitle from PDF title page (viewed on Apr. 30, 2009)."Draft consensus guideline"."Current step 2 version, dated November 1, 2007".Includes bibliographical references: (page [4]).Evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on test for particulate contamination, sub-visible particlesDrugsMicrobiologyTestingDrugsMicrobiologyTesting.Center for Biologics Evaluation and Research (U.S.)International Conference on Harmonisation.GPOGPOBOOK9910698901103321Q4B, annex 3, evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on test for particulate contamination, sub-visible particles3191535UNINA